Salivary biglycan-neo-epitope-BGN(262): A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena

OBJECTIVE: We aimed to delineate a novel soluble Biglycan Neo-epitope-BGN262 in saliva from young reference and osteoarthritic horses in conjunction with the influence of short-term training exercise, riding surface hardness, circadian rhythm, and feeding on its soluble levels. DESIGN: A custom-made...

Descripción completa

Detalles Bibliográficos
Autores principales: Adepu, S., Lord, M., Hugoh, Z., Nyström, S., Mattsson-Hulten, L., Abrahamsson-Aurell, K., Lützelschwab, C., Skiöldebrand, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
ORIGINAL PAPER
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033749/
https://www.ncbi.nlm.nih.gov/pubmed/36968250
http://dx.doi.org/10.1016/j.ocarto.2023.100354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033749/
https://www.ncbi.nlm.nih.gov/pubmed/36968250
http://dx.doi.org/10.1016/j.ocarto.2023.100354

Ejemplares similares